# Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

> **NCT04492163** · PHASE2 · COMPLETED · sponsor: **NovoCure GmbH** · enrollment: 25 (actual)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DEVICE:** TTFields

## Key facts

- **NCT ID:** NCT04492163
- **Lead sponsor:** NovoCure GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-14
- **Primary completion:** 2023-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04492163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04492163, "Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04492163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*